BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
BioWorld 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, December 23, 2024
See today's BioWorld MedTech
Home
» Nanodx gets $18M to pursue fast, easy COVID-19, TBI tests; aims for market shortly
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Nanodx gets $18M to pursue fast, easy COVID-19, TBI tests; aims for market shortly
July 2, 2020
By
Stacy Lawrence
No Comments
Startup Nanodiagnostics Inc. has been working for years toward a panel of point-of-care tests, helmed by one for traumatic brain injury.
BioWorld MedTech
Financings
Neurology/psychiatric
Coronavirus
Series C
Diagnostics
